Počet záznamů: 1  

Mechanism of action and efficacy of RX-111, a thieno[2,3-c]pyridine derivative and small molecule inhibitor of protein interaction with glycosaminoglycans (SMIGs), in delayed-type hypersensitivity, TNBS-induced colitis and experimental autoimmune encephalomyelitis

  1. 1.
    SYSNO ASEP0461932
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevMechanism of action and efficacy of RX-111, a thieno[2,3-c]pyridine derivative and small molecule inhibitor of protein interaction with glycosaminoglycans (SMIGs), in delayed-type hypersensitivity, TNBS-induced colitis and experimental autoimmune encephalomyelitis
    Tvůrce(i) Harris, N. (IL)
    Koppel, J. (SK)
    Zsila, F. (HU)
    Juhás, Štefan (UZFG-Y) RID, ORCID
    Ilková, G. (SK)
    Kogan, F. Y. (IL)
    Lahmy, O. (IL)
    Wildbaum, G. (IL)
    Karin, N. (IL)
    Zhuk, R. (IL)
    Gregor, P. (IL)
    Zdroj.dok.Inflammation Research - ISSN 1023-3830
    Roč. 65, č. 4 (2016), s. 285-294
    Poč.str.10 s.
    Forma vydáníTištěná - P
    Jazyk dok.eng - angličtina
    Země vyd.CH - Švýcarsko
    Klíč. slovasmall molecule drug ; glycosaminoglycan ; heparin binding protein ; heparan sulfate ; inflammation ; autoimmune disease
    Vědní obor RIVEB - Genetika a molekulární biologie
    Institucionální podporaUZFG-Y - RVO:67985904
    UT WOS000372288200004
    EID SCOPUS84961061068
    DOI10.1007/s00011-016-0915-4
    AnotaceElucidate the mechanism of action of the small molecule inhibitor of protein binding to glycosaminoglycans, RX-111 and assay its anti-inflammatory activity in animal models of inflammatory disease.
    The glycosaminoglycan, heparin, was used in the mechanism of action study of RX-111. Human T lymphocytes and umbilical vein endothelial cells were used to assay the in vitro activity of RX-111. Mouse and rat models of disease were used to assay the anti-inflammatory activity of RX-111 in vivo.
    Circular dichroism and UV/Vis absorption spectroscopy were used to study the binding of RX-111 to the glycosaminoglycan, heparin. T lymphocyte rolling on endothelial cells under shear flow was used to assay RX-111 activity in vitro. Delayed-type hypersensitivity (DTH) and tri-nitrobenzene sulfonic acid (TNBS)-induced colitis in mice and experimental autoimmune encephalomyelitis (EAE) in rats were used to assay anti-inflammatory activity of RX-111 in vivo.
    RX-111 was shown to bind directly to heparin. It inhibited leukocyte rolling on endothelial cells under shear flow and reduced inflammation in the mouse model of DTH. RX-111 was efficacious in the mouse model of inflammatory bowel disease, TNBS-induced colitis and the rat model of multiple sclerosis, EAE.
    RX-111 exercises its broad spectrum anti-inflammatory activity by a singular mechanism of action, inhibition of protein binding to the cell surface GAG, heparan sulfate. RX-111 and related thieno[2,3-c]pyridine derivatives are potential therapeutics for the treatment of inflammatory and autoimmune diseases.
    PracovištěÚstav živočišné fyziologie a genetiky
    KontaktJana Zásmětová, knihovna@iapg.cas.cz, Tel.: 315 639 554
    Rok sběru2017
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.